表紙:移植用HLAタイピングの世界市場 (2023年~2032年):市場規模 (技術・製品&サービス・用途・エンドユーザー別)・地域別展望・成長の潜在性・競合市場シェア・予測
市場調査レポート
商品コード
1157295

移植用HLAタイピングの世界市場 (2023年~2032年):市場規模 (技術・製品&サービス・用途・エンドユーザー別)・地域別展望・成長の潜在性・競合市場シェア・予測

HLA Typing for Transplant Market Size By Technology, By Product And Services, By Application, By End-Use, Industry Analysis Report, Industry Analysis Report, Regional Outlook Growth Potential, Competitive Market Share & Forecast, 2023-2032

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 255 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
移植用HLAタイピングの世界市場 (2023年~2032年):市場規模 (技術・製品&サービス・用途・エンドユーザー別)・地域別展望・成長の潜在性・競合市場シェア・予測
出版日: 2022年11月14日
発行: Global Market Insights Inc.
ページ情報: 英文 255 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

移植用HLAタイピングの市場は、分子アッセイの技術開発により、2032年にかけて大きな成長を記録すると予測されています。

企業各社は、高い精度レベルとより高い信頼性を提供するHLAタイピングのための新しいプラットフォームの開発に重点を置いています。また、臓器移植手術の増加や老年人口における慢性疾患の有病率の上昇といった要因も市場の進展を後押しすると考えられています。

製品・サービス別で見ると、機器の部門が2022年に1億4,800万米ドルを示し、2023年から2032年にかけても大きく成長すると予測されています。先進技術の導入より、より優れた正確な結果を短時間で提供する機器の開発が促進されています。用途別では、診断部門が2022年に5億7,500万米ドルに近い規模を示し、2032年にかけても大きく成長する見通しです。

当レポートでは、世界の移植用HLAタイピングの市場を調査し、市場概要、市場成長への各種影響因子の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 移植用HLAタイピング産業の考察

  • 産業の分類
  • 産業情勢
  • 産業への影響要因
    • 促進要因
    • 抑制要因
  • 成長性分析
  • COVID-19:影響分析
  • HLAタイピングテストの年間実施総数:地域別
  • 価格分析
  • 社内ラボベースのHLAタイピングテスト vs 診断メーカーのキット
  • 各種HLAタイピング法の進化
  • 規制状況
  • ポーターの分析
  • PESTEL分析

第4章 競合情勢

  • 企業の市場シェア分析
  • 企業マトリックス分析
  • 戦略ダッシュボード

第5章 移植用HLAタイピング市場:技術別

  • 主要動向
  • 非分子アッセイ
    • 血清学的アッセイ
    • 混合リンパ球培養アッセイ
  • 分子アッセイ
    • PCRベース
    • シーケンスベース

第6章 移植用HLAタイピング市場:製品・サービス別

  • 主要動向
  • 機器
  • 試薬・消耗品
  • ソフトウェア
  • サービス

第7章 移植用HLAタイピング市場:用途別

  • 主要動向
  • 診断
  • 研究

第8章 移植用HLAタイピング市場:エンドユーザー別

  • 主要動向
  • 病院
  • 診断ラボ
  • 学術・研究機関センター

第9章 移植用HLAタイピング市場:地域別

  • 主要動向
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 企業プロファイル

  • Abbott Laboratories
  • Bio-Rad Laboratories
  • BioReference Laboratories
  • CareDx, Inc.
  • GenDx
  • Illumina Inc.
  • Immucor Inc.
  • Inno-train Diagnostik GmbH
  • Luminex Corporation
  • Omixon, Inc
  • Pacific Biosciences of California, Inc
  • Qiagen N.V.
  • F. Hoffmann-La Roche Ltd
  • Thermo-Fisher Scientific Inc.
  • Fujirebio
  • BAG Diagnostic GmbH
  • GMSbiotech, Inc.
  • Biofortuna Limited
  • TBG Diagnostics Limited
図表

Data Tables

  • TABLE 1. Global HLA typing for transplant market, 2018 - 2022 (USD Million)
  • TABLE 2. Global HLA typing for transplant market, 2023 - 2032 (USD Million)
  • TABLE 3. Global HLA typing for transplant market, by technology, 2018 - 2022 (USD Million)
  • TABLE 4. Global HLA typing for transplant market, by technology, 2023 - 2032 (USD Million)
  • TABLE 5. Global HLA typing for transplant market, by product and services, 2018 - 2022 (USD Million)
  • TABLE 6. Global HLA typing for transplant market, by product and services, 2023 - 2032 (USD Million)
  • TABLE 7. Global HLA typing for transplant market, by application, 2018 - 2022 (USD Million)
  • TABLE 8. Global HLA typing for transplant market, by application, 2023 - 2032 (USD Million)
  • TABLE 9. Global HLA typing for transplant market, by end-use, 2018 - 2022 (USD Million)
  • TABLE 10. Global HLA typing for transplant market, by end-use, 2023 - 2032 (USD Million)
  • TABLE 11. Global HLA typing for transplant market, by region, 2018 - 2022 (USD Million)
  • TABLE 12. Global HLA typing for transplant market, by region, 2023 - 2032 (USD Million)
  • TABLE 13. Industry impact forces
  • TABLE 14. Total number of HLA typing test performed annually, by region, 2017-2021 (000' Units)
  • TABLE 15. Global HLA typing average test price, 2021 (USD)
  • TABLE 16. Comparison between in-house lab-based HLA typing test and commercially available test kits
  • TABLE 17. Non-molecular assays market, by region, 2018 - 2022, (USD Million)
  • TABLE 18. Non-molecular assays market, by region, 2023 - 2032, (USD Million)
  • TABLE 19. Serological assays market, by region, 2018 - 2022, (USD Million)
  • TABLE 20. Serological assays market, by region, 2023-2032, (USD Million)
  • TABLE 21. Mixed lymphocyte culture assays market, by region, 2018 - 2022, (USD Million)
  • TABLE 22. Mixed lymphocyte culture assays market, by region, 2023-2032, (USD Million)
  • TABLE 23. Molecular assays market, by region, 2018 - 2022, (USD Million)
  • TABLE 24. Molecular assays market, by region, 2023-2032, (USD Million)
  • TABLE 25. PCR based molecular assays market, by region, 2018 - 2022, (USD Million)
  • TABLE 26. PCR based molecular assays market, by region, 2023-2032, (USD Million)
  • TABLE 27. Sequencing based molecular assays market, by region, 2018 - 2022, (USD Million)
  • TABLE 28. Sequencing based molecular assays market, by region, 2023-2032, (USD Million)
  • TABLE 29. Sanger sequencing market, by region, 2018 - 2022, (USD Million)
  • TABLE 30. Sanger sequencing market, by region, 2023-2032, (USD Million)
  • TABLE 31. Next generation sequencing market, by region, 2018 - 2022, (USD Million)
  • TABLE 32. Next generation sequencing market, by region, 2023-2032, (USD Million)
  • TABLE 33. Instruments market, by region, 2018 - 2022, (USD Million)
  • TABLE 34. Instruments market, by region, 2023-2032, (USD Million)
  • TABLE 35. Reagents and consumables market, by region, 2018 - 2022, (USD Million)
  • TABLE 36. Reagents and consumables market, by region, 2023-2032, (USD Million)
  • TABLE 37. Software market, by region, 2018 - 2022, (USD Million)
  • TABLE 38. Software market, by region, 2023-2032, (USD Million)
  • TABLE 39. Services market, by region, 2018 - 2022, (USD Million)
  • TABLE 40. Services market, by region, 2023-2032, (USD Million)
  • TABLE 41. Diagnostics market, by region, 2018 - 2022, (USD Million)
  • TABLE 42. Diagnostics market, by region, 2023-2032, (USD Million)
  • TABLE 43. Research market, by region, 2018 - 2022, (USD Million)
  • TABLE 44. Research market, by region, 2023-2032, (USD Million)
  • TABLE 45. Hospitals market, by region, 2018 - 2022, (USD Million)
  • TABLE 46. Hospitals market, by region, 2023-2032, (USD Million)
  • TABLE 47. Diagnostic labs market, by region, 2018 - 2022, (USD Million)
  • TABLE 48. Diagnostic labs market, by region, 2023-2032, (USD Million)
  • TABLE 49. Academic and research institutes centers market, by region, 2018 - 2022, (USD Million)
  • TABLE 50. Academic and research institutes centers market, by region, 2023-2032, (USD Million)
  • TABLE 51. North America HLA typing for transplant market, by country, 2018-2022, (USD Million)
  • TABLE 52. North America HLA typing for transplant market, by country, 2023-2032, (USD Million)
  • TABLE 53. North America HLA typing for transplant market, by technology, 2018-2022, (USD Million)
  • TABLE 54. North America HLA typing for transplant market, by technology, 2023-2032, (USD Million)
  • TABLE 55. North America HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
  • TABLE 56. North America HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
  • TABLE 57. North America HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
  • TABLE 58. North America HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
  • TABLE 59. North America HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
  • TABLE 60. North America HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
  • TABLE 61. North America HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
  • TABLE 62. North America HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
  • TABLE 63. North America HLA typing for transplant market, by application, 2018-2022, (USD Million)
  • TABLE 64. North America HLA typing for transplant market, by application, 2023-2032, (USD Million)
  • TABLE 65. North America HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
  • TABLE 66. North America HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
  • TABLE 67. U.S. HLA typing for transplant market, by technology, 2018-2022, (USD Million)
  • TABLE 68. U.S. HLA typing for transplant market, by technology, 2023-2032, (USD Million)
  • TABLE 69. U.S. HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
  • TABLE 70. U.S. HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
  • TABLE 71. U.S. HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
  • TABLE 72. U.S. HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
  • TABLE 73. U.S. HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
  • TABLE 74. U.S. HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
  • TABLE 75. U.S. HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
  • TABLE 76. U.S. HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
  • TABLE 77. U.S. HLA typing for transplant market, by application, 2018-2022, (USD Million)
  • TABLE 78. U.S. HLA typing for transplant market, by application, 2023-2032, (USD Million)
  • TABLE 79. U.S. HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
  • TABLE 80. U.S. HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
  • TABLE 81. Canada HLA typing for transplant market, by technology, 2018-2022, (USD Million)
  • TABLE 82. Canada HLA typing for transplant market, by technology, 2023-2032, (USD Million)
  • TABLE 83. Canada HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
  • TABLE 84. Canada HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
  • TABLE 85. Canada HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
  • TABLE 86. Canada HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
  • TABLE 87. Canada HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
  • TABLE 88. Canada HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
  • TABLE 89. Canada HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
  • TABLE 90. Canada HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
  • TABLE 91. Canada HLA typing for transplant market, by application, 2018-2022, (USD Million)
  • TABLE 92. Canada HLA typing for transplant market, by application, 2023-2032, (USD Million)
  • TABLE 93. Canada HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
  • TABLE 94. Canada HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
  • TABLE 95. Europe HLA typing for transplant market, by country, 2018-2022, (USD Million)
  • TABLE 96. Europe HLA typing for transplant market, by country, 2023-2032, (USD Million)
  • TABLE 97. Europe HLA typing for transplant market, by technology, 2018-2022, (USD Million)
  • TABLE 98. Europe HLA typing for transplant market, by technology, 2023-2032, (USD Million)
  • TABLE 99. Europe HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
  • TABLE 100. Europe HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
  • TABLE 101. Europe HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
  • TABLE 102. Europe HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
  • TABLE 103. Europe HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
  • TABLE 104. Europe HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
  • TABLE 105. Europe HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
  • TABLE 106. Europe HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
  • TABLE 107. Europe HLA typing for transplant market, by application, 2018-2022, (USD Million)
  • TABLE 108. Europe HLA typing for transplant market, by application, 2023-2032, (USD Million)
  • TABLE 109. Europe HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
  • TABLE 110. Europe HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
  • TABLE 111. Germany HLA typing for transplant market, by technology, 2018-2022, (USD Million)
  • TABLE 112. Germany HLA typing for transplant market, by technology, 2023-2032, (USD Million)
  • TABLE 113. Germany HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
  • TABLE 114. Germany HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
  • TABLE 115. Germany HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
  • TABLE 116. Germany HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
  • TABLE 117. Germany HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
  • TABLE 118. Germany HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
  • TABLE 119. Germany HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
  • TABLE 120. Germany HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
  • TABLE 121. Germany HLA typing for transplant market, by application, 2018-2022, (USD Million)
  • TABLE 122. Germany HLA typing for transplant market, by application, 2023-2032, (USD Million)
  • TABLE 123. Germany HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
  • TABLE 124. Germany HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
  • TABLE 125. UK HLA typing for transplant market, by technology, 2018-2022, (USD Million)
  • TABLE 126. UK HLA typing for transplant market, by technology, 2023-2032, (USD Million)
  • TABLE 127. UK HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
  • TABLE 128. UK HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
  • TABLE 129. UK HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
  • TABLE 130. UK HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
  • TABLE 131. UK HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
  • TABLE 132. UK HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
  • TABLE 133. UK HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
  • TABLE 134. UK HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
  • TABLE 135. UK HLA typing for transplant market, by application, 2018-2022, (USD Million)
  • TABLE 136. UK HLA typing for transplant market, by application, 2023-2032, (USD Million)
  • TABLE 137. UK HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
  • TABLE 138. UK HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
  • TABLE 139. France HLA typing for transplant market, by technology, 2018-2022, (USD Million)
  • TABLE 140. France HLA typing for transplant market, by technology, 2023-2032, (USD Million)
  • TABLE 141. France HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
  • TABLE 142. France HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
  • TABLE 143. France HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
  • TABLE 144. France HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
  • TABLE 145. France HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
  • TABLE 146. France HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
  • TABLE 147. France HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
  • TABLE 148. France HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
  • TABLE 149. France HLA typing for transplant market, by application, 2018-2022, (USD Million)
  • TABLE 150. France HLA typing for transplant market, by application, 2023-2032, (USD Million)
  • TABLE 151. France HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
  • TABLE 152. France HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
  • TABLE 153. Italy HLA typing for transplant market, by technology, 2018-2022, (USD Million)
  • TABLE 154. Italy HLA typing for transplant market, by technology, 2023-2032, (USD Million)
  • TABLE 155. Italy HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
  • TABLE 156. Italy HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
  • TABLE 157. Italy HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
  • TABLE 158. Italy HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
  • TABLE 159. Italy HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
  • TABLE 160. Italy HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
  • TABLE 161. Italy HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
  • TABLE 162. Italy HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
  • TABLE 163. Italy HLA typing for transplant market, by application, 2018-2022, (USD Million)
  • TABLE 164. Italy HLA typing for transplant market, by application, 2023-2032, (USD Million)
  • TABLE 165. Italy HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
  • TABLE 166. Italy HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
  • TABLE 167. Spain HLA typing for transplant market, by technology, 2018-2022, (USD Million)
  • TABLE 168. Spain HLA typing for transplant market, by technology, 2023-2032, (USD Million)
  • TABLE 169. Spain HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
  • TABLE 170. Spain HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
  • TABLE 171. Spain HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
  • TABLE 172. Spain HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
  • TABLE 173. Spain HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
  • TABLE 174. Spain HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
  • TABLE 175. Spain HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
  • TABLE 176. Spain HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
  • TABLE 177. Spain HLA typing for transplant market, by application, 2018-2022, (USD Million)
  • TABLE 178. Spain HLA typing for transplant market, by application, 2023-2032, (USD Million)
  • TABLE 179. Spain HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
  • TABLE 180. Spain HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
  • TABLE 181. Russia HLA typing for transplant market, by technology, 2018-2022, (USD Million)
  • TABLE 182. Russia HLA typing for transplant market, by technology, 2023-2032, (USD Million)
  • TABLE 183. Russia HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
  • TABLE 184. Russia HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
  • TABLE 185. Russia HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
  • TABLE 186. Russia HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
  • TABLE 187. Russia HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
  • TABLE 188. Russia HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
  • TABLE 189. Russia HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
  • TABLE 190. Russia HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
  • TABLE 191. Russia HLA typing for transplant market, by application, 2018-2022, (USD Million)
  • TABLE 192. Russia HLA typing for transplant market, by application, 2023-2032, (USD Million)
  • TABLE 193. Russia HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
  • TABLE 194. Russia HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
  • TABLE 195. Asia Pacific HLA typing for transplant market, by country, 2018-2022, (USD Million)
  • TABLE 196. Asia Pacific HLA typing for transplant market, by country, 2023-2032, (USD Million)
  • TABLE 197. Asia Pacific HLA typing for transplant market, by technology, 2018-2022, (USD Million)
  • TABLE 198. Asia Pacific HLA typing for transplant market, by technology, 2023-2032, (USD Million)
  • TABLE 199. Asia Pacific HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
  • TABLE 200. Asia Pacific HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
  • TABLE 201. Asia Pacific HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
  • TABLE 202. Asia Pacific HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
  • TABLE 203. Asia Pacific HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
  • TABLE 204. Asia Pacific HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
  • TABLE 205. Asia Pacific HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
  • TABLE 206. Asia Pacific HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
  • TABLE 207. Asia Pacific HLA typing for transplant market, by application, 2018-2022, (USD Million)
  • TABLE 208. Asia Pacific HLA typing for transplant market, by application, 2023-2032, (USD Million)
  • TABLE 209. Asia Pacific HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
  • TABLE 210. Asia Pacific HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
  • TABLE 211. China HLA typing for transplant market, by technology, 2018-2022, (USD Million)
  • TABLE 212. China HLA typing for transplant market, by technology, 2023-2032, (USD Million)
  • TABLE 213. China HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
  • TABLE 214. China HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
  • TABLE 215. China HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
  • TABLE 216. China HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
  • TABLE 217. China HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
  • TABLE 218. China HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
  • TABLE 219. China HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
  • TABLE 220. China HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
  • TABLE 221. China HLA typing for transplant market, by application, 2018-2022, (USD Million)
  • TABLE 222. China HLA typing for transplant market, by application, 2023-2032, (USD Million)
  • TABLE 223. China HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
  • TABLE 224. China HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
  • TABLE 225. India HLA typing for transplant market, by technology, 2018-2022, (USD Million)
  • TABLE 226. India HLA typing for transplant market, by technology, 2023-2032, (USD Million)
  • TABLE 227. India HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
  • TABLE 228. India HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
  • TABLE 229. India HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
  • TABLE 230. India HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
  • TABLE 231. India HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
  • TABLE 232. India HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
  • TABLE 233. India HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
  • TABLE 234. India HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
  • TABLE 235. India HLA typing for transplant market, by application, 2018-2022, (USD Million)
  • TABLE 236. India HLA typing for transplant market, by application, 2023-2032, (USD Million)
  • TABLE 237. India HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
  • TABLE 238. India HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
  • TABLE 239. Japan HLA typing for transplant market, by technology, 2018-2022, (USD Million)
  • TABLE 240. Japan HLA typing for transplant market, by technology, 2023-2032, (USD Million)
  • TABLE 241. Japan HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
  • TABLE 242. Japan HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
  • TABLE 243. Japan HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
  • TABLE 244. Japan HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
  • TABLE 245. Japan HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
  • TABLE 246. Japan HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
  • TABLE 247. Japan HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
  • TABLE 248. Japan HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
  • TABLE 249. Japan HLA typing for transplant market, by application, 2018-2022, (USD Million)
  • TABLE 250. Japan HLA typing for transplant market, by application, 2023-2032, (USD Million)
  • TABLE 251. Japan HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
  • TABLE 252. Japan HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
  • TABLE 253. Australia HLA typing for transplant market, by technology, 2018-2022, (USD Million)
  • TABLE 254. Australia HLA typing for transplant market, by technology, 2023-2032, (USD Million)
  • TABLE 255. Australia HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
  • TABLE 256. Australia HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
  • TABLE 257. Australia HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
  • TABLE 258. Australia HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
  • TABLE 259. Australia HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
  • TABLE 260. Australia HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
  • TABLE 261. Australia HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
  • TABLE 262. Australia HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
  • TABLE 263. Australia HLA typing for transplant market, by application, 2018-2022, (USD Million)
  • TABLE 264. Australia HLA typing for transplant market, by application, 2023-2032, (USD Million)
  • TABLE 265. Australia HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
  • TABLE 266. Australia HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
  • TABLE 267. Latin America HLA typing for transplant market, by country, 2018-2022, (USD Million)
  • TABLE 268. Latin America HLA typing for transplant market, by country, 2023-2032, (USD Million)
  • TABLE 269. Latin America HLA typing for transplant market, by technology, 2018-2022, (USD Million)
  • TABLE 270. Latin America HLA typing for transplant market, by technology, 2023-2032, (USD Million)
  • TABLE 271. Latin America HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
  • TABLE 272. Latin America HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
  • TABLE 273. Latin America HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
  • TABLE 274. Latin America HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
  • TABLE 275. Latin America HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
  • TABLE 276. Latin America HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
  • TABLE 277. Latin America HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
  • TABLE 278. Latin America HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
  • TABLE 279. Latin America HLA typing for transplant market, by application, 2018-2022, (USD Million)
  • TABLE 280. Latin America HLA typing for transplant market, by application, 2023-2032, (USD Million)
  • TABLE 281. Latin America HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
  • TABLE 282. Latin America HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
  • TABLE 283. Brazil HLA typing for transplant market, by technology, 2018-2022, (USD Million)
  • TABLE 284. Brazil HLA typing for transplant market, by technology, 2023-2032, (USD Million)
  • TABLE 285. Brazil HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
  • TABLE 286. Brazil HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
  • TABLE 287. Brazil HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
  • TABLE 288. Brazil HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
  • TABLE 289. Brazil HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
  • TABLE 290. Brazil HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
  • TABLE 291. Brazil HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
  • TABLE 292. Brazil HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
  • TABLE 293. Brazil HLA typing for transplant market, by application, 2018-2022, (USD Million)
  • TABLE 294. Brazil HLA typing for transplant market, by application, 2023-2032, (USD Million)
  • TABLE 295. Brazil HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
  • TABLE 296. Brazil HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
  • TABLE 297. Mexico HLA typing for transplant market, by technology, 2018-2022, (USD Million)
  • TABLE 298. Mexico HLA typing for transplant market, by technology, 2023-2032, (USD Million)
  • TABLE 299. Mexico HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
  • TABLE 300. Mexico HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
  • TABLE 301. Mexico HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
  • TABLE 302. Mexico HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
  • TABLE 303. Mexico HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
  • TABLE 304. Mexico HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
  • TABLE 305. Mexico HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
  • TABLE 306. Mexico HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
  • TABLE 307. Mexico HLA typing for transplant market, by application, 2018-2022, (USD Million)
  • TABLE 308. Mexico HLA typing for transplant market, by application, 2023-2032, (USD Million)
  • TABLE 309. Mexico HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
  • TABLE 310. Mexico HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
  • TABLE 311. MEA HLA typing for transplant market, by country, 2018-2022, (USD Million)
  • TABLE 312. MEA HLA typing for transplant market, by country, 2023-2032, (USD Million)
  • TABLE 313. MEA HLA typing for transplant market, by technology, 2018-2022, (USD Million)
  • TABLE 314. MEA HLA typing for transplant market, by technology, 2023-2032, (USD Million)
  • TABLE 315. MEA HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
  • TABLE 316. MEA HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
  • TABLE 317. MEA HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
  • TABLE 318. MEA HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
  • TABLE 319. MEA HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
  • TABLE 320. MEA HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
  • TABLE 321. MEA HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
  • TABLE 322. MEA HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
  • TABLE 323. MEA HLA typing for transplant market, by application, 2018-2022, (USD Million)
  • TABLE 324. MEA HLA typing for transplant market, by application, 2023-2032, (USD Million)
  • TABLE 325. MEA HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
  • TABLE 326. MEA HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
  • TABLE 327. South Africa HLA typing for transplant market, by technology, 2018-2022, (USD Million)
  • TABLE 328. South Africa HLA typing for transplant market, by technology, 2023-2032, (USD Million)
  • TABLE 329. South Africa HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
  • TABLE 330. South Africa HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
  • TABLE 331. South Africa HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
  • TABLE 332. South Africa HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
  • TABLE 333. South Africa HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
  • TABLE 334. South Africa HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
  • TABLE 335. South Africa HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
  • TABLE 336. South Africa HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
  • TABLE 337. South Africa HLA typing for transplant market, by application, 2018-2022, (USD Million)
  • TABLE 338. South Africa HLA typing for transplant market, by application, 2023-2032, (USD Million)
  • TABLE 339. South Africa HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
  • TABLE 340. South Africa HLA typing for transplant market, by end-use, 2023-2032, (USD Million)
  • TABLE 341. Saudi Arabia HLA typing for transplant market, by technology, 2018-2022, (USD Million)
  • TABLE 342. Saudi Arabia HLA typing for transplant market, by technology, 2023-2032, (USD Million)
  • TABLE 343. Saudi Arabia HLA typing for transplant market, by non-molecular assays, 2018-2022, (USD Million)
  • TABLE 344. Saudi Arabia HLA typing for transplant market, by non-molecular assays, 2023-2032, (USD Million)
  • TABLE 345. Saudi Arabia HLA typing for transplant market, by molecular assays, 2018-2022, (USD Million)
  • TABLE 346. Saudi Arabia HLA typing for transplant market, by molecular assays, 2023-2032, (USD Million)
  • TABLE 347. Saudi Arabia HLA typing for transplant market, by sequencing based molecular assays, 2018-2022, (USD Million)
  • TABLE 348. Saudi Arabia HLA typing for transplant market, by sequencing based molecular assays, 2023-2032, (USD Million)
  • TABLE 349. Saudi Arabia HLA typing for transplant market, by product and services, 2018-2022, (USD Million)
  • TABLE 350. Saudi Arabia HLA typing for transplant market, by product and services, 2023-2032, (USD Million)
  • TABLE 351. Saudi Arabia HLA typing for transplant market, by application, 2018-2022, (USD Million)
  • TABLE 352. Saudi Arabia HLA typing for transplant market, by application, 2023-2032, (USD Million)
  • TABLE 353. Saudi Arabia HLA typing for transplant market, by end-use, 2018-2022, (USD Million)
  • TABLE 354. Saudi Arabia HLA typing for transplant market, by end-use, 2023-2032, (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach
  • FIG. 2 Breakdown of primary participants
  • FIG. 3 HLA typing for transplant industry 360 degree synopsis, 2018 - 2032
  • FIG. 4 Industry segmentation
  • FIG. 5 Industry landscape, 2018-2032 (USD Million)
  • FIG. 6 U.S. transplantation, by organ, 2021
  • FIG. 7 Proportion for various organs for which patients were on the waiting list in the U.S. (2021)
  • FIG. 8 Growth potential analysis, by technology
  • FIG. 9 Growth potential analysis, by product and services
  • FIG. 10 Growth potential analysis, by application
  • FIG. 11 Growth potential analysis, by end-use
  • FIG. 12 Company market share analysis, 2022
  • FIG. 13 Company matrix analysis, 2022
  • FIG. 14 Strategy dashboard, 2022
  • FIG. 15 Key segment trends, by technology
  • FIG. 16 Key segment trends, by product & services
  • FIG. 17 Key segment trends, by application
  • FIG. 18 Key segment trends, by end-use
  • FIG. 19 Key regional trends
目次
Product Code: 1653

HLA Typing for Transplant Market is speculated to record significant growth by 2032 fueled by technological developments in molecular assays. Companies are focusing on developing novel platforms for HLA typing that offer high accuracy levels and more reliability.

For instance, in May 2022, CareDx announced presenting its latest innovations in AlloSeq portfolio at European EFI 2022 Conference. The company put forth information on its pre- and post-Alloseq transplant solutions for human leukocyte antigen typing. These include QTYPE and post-transplant hematopoietic stem cell and organ transplant surveillance.

Furthermore, factors like rise in organ transplantation procedures and increasing prevalence of chronic disorder among geriatric population would support the market progression.

HLA typing for transplant market is bifurcated into technology, applications, products and services, end-use, and regional landscape.

In terms of products and services, the instrument segment was valued at USD 148 million in 2022 and is predicted to grow significantly between 2023-2032. HLA typing for transplant instruments are being developed with emphasis on cost effectiveness and function. Introduction to advanced technologies have expedited the development of instruments that deliver better and accurate results in less time.

Based on the application, HLA typing for transplant market from diagnostics segment would gain appreciable impetus through 2032. In 2022, the segment accounted for nearly USD 575 million remuneration. Growing awareness initiatives for organ donations by private, public institutions, and NGOs is estimated to enhance organ transplantation, generating lucrative opportunities for segmental expansion. In India, more than 60 NGOs resolved to launch a national campaign for organ donation nationwide.

Academic and research institutes are observing increased prominence across HLA typing for transplant market. HLA typing for research activities is preferred due to the introduction of instrument and technologies that allow scientists to perform assays. Various research projects are underway. For example, the International Center for Blood Marrow Transplant Research announced partnering with Medical College for Wisconsin and National Marrow Donor Program. The alliance is aimed at the advancement of HCT and cellular therapy to improve survival rate of patients and their quality of life.

Such programs and initiatives would foster the segmental growth over the coming years. Incidentally, the academic and research institute segment is poised to grow at more than 8% CAGR during 2023-2032.

Considering the regional point of view, Asia Pacific HLA typing for transplant market is foreseen to gain substantial traction through 2032. Surging demand for high-resolution HLA genotyping, adoption of advanced technologies for stem cell and organ donations, and rising government initiatives to support development of HLA typing for enhanced transplantation procedures would contribute to the regional market expansion.

Notable companies operating in HLA typing for transplant business are CareDx, Abbott Laboratories, GenDx, BioReference Laboratories, and Luminex Corporation, amongst others.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definitions
  • 1.2 Base estimates & working
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia Pacific
    • 1.2.4 Latin America
    • 1.2.5 Middle East & Africa
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid Sources
      • 1.5.1.2 Unpaid Sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 HLA typing for transplant industry 360 degree synopsis, 2018 - 2032
  • 2.2 Business trends
    • 2.2.1 Technology trends
    • 2.2.2 Product and services trends
    • 2.2.3 Application trends
    • 2.2.4 End-use trends
    • 2.2.5 Regional trends

Chapter 3 HLA Typing for Transplant Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2018 - 2032 (USD Million)
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing number of solid organ transplants
      • 3.3.1.2 Technological advancements
      • 3.3.1.3 Increasing geriatric population
    • 3.3.2 Restraints
      • 3.3.2.1 Significant gap between number of organs donated and organs required
      • 3.3.2.2 High cost of molecular tests
  • 3.4 Growth potential analysis
    • 3.4.1 By technology
    • 3.4.2 By product and services
    • 3.4.3 By application
    • 3.4.4 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Total number of HLA typing test performed annually, by region, 2017-2021 (000' Units)
  • 3.7 Pricing analysis, 2021
  • 3.8 In-house lab-based HLA typing test v/s kits from diagnostic manufacturer
  • 3.9 Evolution of different HLA typing method
    • 3.9.1 PCR-based testing method
    • 3.9.2 NGS-based testing method
  • 3.10 Regulatory landscape
    • 3.10.1 U.S.
    • 3.10.2 Europe
  • 3.11 Porter's analysis
    • 3.11.1 Bargaining power of buyers
    • 3.11.2 Bargaining power of suppliers
    • 3.11.3 Threat of new entrants
    • 3.11.4 Threat of substitutes
    • 3.11.5 Industry rivalry
  • 3.12 PESTEL analysis
    • 3.12.1 Political
    • 3.12.1 Economic
    • 3.12.1 Social
    • 3.12.1 Technological
    • 3.12.1 Environmental
    • 3.12.2 Legal

Chapter 4 Competition Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company market share analysis, 2022
  • 4.3 Company matrix analysis, 2022
  • 4.4 Strategy dashboard, 2022

Chapter 5 HLA Typing for Transplant Market, By Technology

  • 5.1 Key segment trends
  • 5.2 Non-molecular assays
    • 5.2.1 Market size, by region, 2018-2032 (USD Million)
    • 5.2.2 Serological assays
      • 5.2.2.1 Market size, by region, 2018-2032 (USD Million)
    • 5.2.3 Mixed lymphocyte culture assays
      • 5.2.3.1 Market size, by region, 2018-2032 (USD Million)
  • 5.3 Molecular assays
    • 5.3.1 Market size, by region, 2018-2032 (USD Million)
    • 5.3.2 PCR based molecular assays
      • 5.3.2.1 Market size, by region, 2018-2032 (USD Million)
    • 5.3.3 Sequencing based molecular assays
      • 5.3.3.1 Market size, by region, 2018-2032 (USD Million)
      • 5.3.3.2 Sanger sequencing
        • 5.3.3.2.1 Market size, by region, 2018-2032 (USD Million)
      • 5.3.3.3 Next generation sequencing
        • 5.3.3.3.1 Market size, by region, 2018-2032 (USD Million)

Chapter 6 HLA Typing for Transplant Market, By Product & Services

  • 6.1 Key segment trends
  • 6.2 Instruments
    • 6.2.1 Market size, by region, 2018-2032 (USD Million)
  • 6.3 Reagents and consumables
    • 6.3.1 Market size, by region, 2018-2032 (USD Million)
  • 6.4 Software
    • 6.4.1 Market size, by region, 2018-2032 (USD Million)
  • 6.5 Services
    • 6.5.1 Market size, by region, 2018-2032 (USD Million)

Chapter 7 HLA Typing for Transplant Market, By Application

  • 7.1 Key segment trends
  • 7.2 Diagnostics
    • 7.2.1 Market size, by region, 2018-2032 (USD Million)
  • 7.3 Research
    • 7.3.1 Market size, by region, 2018-2032 (USD Million)

Chapter 8 HLA Typing for Transplant Market, By End-use

  • 8.1 Key segment trends
  • 8.2 Hospitals
    • 8.2.1 Market size, by region, 2018-2032 (USD Million)
  • 8.3 Diagnostic labs
    • 8.3.1 Market size, by region, 2018-2032 (USD Million)
  • 8.4 Academic and research institutes centers
    • 8.4.1 Market size, by region, 2018-2032 (USD Million)

Chapter 9 HLA Typing for Transplant Market, By Region

  • 9.1 Key regional trends
  • 9.2 North America
    • 9.2.1 Market size, by country, 2018-2032 (USD Million)
    • 9.2.2 Market size, by technology, 2018-2032 (USD Million)
      • 9.2.2.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
      • 9.2.2.2 Market size, by molecular assays, 2018-2032 (USD Million)
        • 9.2.2.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
    • 9.2.3 Market size, by product and services, 2018-2032 (USD Million)
    • 9.2.4 Market size, by application, 2018-2032 (USD Million)
    • 9.2.5 Market size, by end-use, 2018-2032 (USD Million)
    • 9.2.6 U.S.
      • 9.2.6.1 Market size, by technology, 2018-2032 (USD Million)
        • 9.2.6.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
        • 9.2.6.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
        • 9.2.6.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
      • 9.2.6.2 Market size, by product and services, 2018-2032 (USD Million)
      • 9.2.6.3 Market size, by application, 2018-2032 (USD Million)
      • 9.2.6.4 Market size, by end-use, 2018-2032 (USD Million)
    • 9.2.7 Canada
      • 9.2.7.1 Market size, by technology, 2018-2032 (USD Million)
        • 9.2.7.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
        • 9.2.7.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
        • 9.2.7.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
      • 9.2.7.2 Market size, by product and services, 2018-2032 (USD Million)
      • 9.2.7.3 Market size, by application, 2018-2032 (USD Million)
      • 9.2.7.4 Market size, by end-use, 2018-2032 (USD Million)
  • 9.3 Europe
    • 9.3.1 Market size, by country, 2018-2032 (USD Million)
    • 9.3.2 Market size, by technology, 2018-2032 (USD Million)
      • 9.3.2.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
      • 9.3.2.2 Market size, by molecular assays, 2018-2032 (USD Million)
        • 9.3.2.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
    • 9.3.3 Market size, by product and services, 2018-2032 (USD Million)
    • 9.3.4 Market size, by application, 2018-2032 (USD Million)
    • 9.3.5 Market size, by end-use, 2018-2032 (USD Million)
    • 9.3.6 Germany
      • 9.3.6.1 Market size, by technology, 2018-2032 (USD Million)
        • 9.3.6.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
        • 9.3.6.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
        • 9.3.6.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
      • 9.3.6.2 Market size, by product and services, 2018-2032 (USD Million)
      • 9.3.6.3 Market size, by application, 2018-2032 (USD Million)
      • 9.3.6.4 Market size, by end-use, 2018-2032 (USD Million)
    • 9.3.7 UK
      • 9.3.7.1 Market size, by technology, 2018-2032 (USD Million)
        • 9.3.7.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
        • 9.3.7.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
        • 9.3.7.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
      • 9.3.7.2 Market size, by product and services, 2018-2032 (USD Million)
      • 9.3.7.3 Market size, by application, 2018-2032 (USD Million)
      • 9.3.7.4 Market size, by end-use, 2018-2032 (USD Million)
    • 9.3.8 France
      • 9.3.8.1 Market size, by technology, 2018-2032 (USD Million)
        • 9.3.8.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
        • 9.3.8.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
        • 9.3.8.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
      • 9.3.8.2 Market size, by product and services, 2018-2032 (USD Million)
      • 9.3.8.3 Market size, by application, 2018-2032 (USD Million)
      • 9.3.8.4 Market size, by end-use, 2018-2032 (USD Million)
    • 9.3.9 Italy
      • 9.3.9.1 Market size, by technology, 2018-2032 (USD Million)
        • 9.3.9.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
        • 9.3.9.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
        • 9.3.9.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
      • 9.3.9.2 Market size, by product and services, 2018-2032 (USD Million)
      • 9.3.9.3 Market size, by application, 2018-2032 (USD Million)
      • 9.3.9.4 Market size, by end-use, 2018-2032 (USD Million)
    • 9.3.10 Spain
      • 9.3.10.1 Market size, by technology, 2018-2032 (USD Million)
        • 9.3.10.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
        • 9.3.10.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
        • 9.3.10.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
      • 9.3.10.2 Market size, by product and services, 2018-2032 (USD Million)
      • 9.3.10.3 Market size, by application, 2018-2032 (USD Million)
      • 9.3.10.4 Market size, by end-use, 2018-2032 (USD Million)
    • 9.3.11 Russia
      • 9.3.11.1 Market size, by technology, 2018-2032 (USD Million)
        • 9.3.11.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
        • 9.3.11.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
        • 9.3.11.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
      • 9.3.11.2 Market size, by product and services, 2018-2032 (USD Million)
      • 9.3.11.3 Market size, by application, 2018-2032 (USD Million)
      • 9.3.11.4 Market size, by end-use, 2018-2032 (USD Million)
  • 9.4 Asia Pacific
    • 9.4.1 Market size, by country, 2018-2032 (USD Million)
    • 9.4.2 Market size, by technology, 2018-2032 (USD Million)
      • 9.4.2.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
      • 9.4.2.2 Market size, by molecular assays, 2018-2032 (USD Million)
        • 9.4.2.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
    • 9.4.3 Market size, by product and services, 2018-2032 (USD Million)
    • 9.4.4 Market size, by application, 2018-2032 (USD Million)
    • 9.4.5 Market size, by end-use, 2018-2032 (USD Million)
    • 9.4.6 China
      • 9.4.6.1 Market size, by technology, 2018-2032 (USD Million)
        • 9.4.6.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
        • 9.4.6.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
        • 9.4.6.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
      • 9.4.6.2 Market size, by product and services, 2018-2032 (USD Million)
      • 9.4.6.3 Market size, by application, 2018-2032 (USD Million)
      • 9.4.6.4 Market size, by end-use, 2018-2032 (USD Million)
    • 9.4.7 India
      • 9.4.7.1 Market size, by technology, 2018-2032 (USD Million)
        • 9.4.7.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
        • 9.4.7.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
        • 9.4.7.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
      • 9.4.7.2 Market size, by product and services, 2018-2032 (USD Million)
      • 9.4.7.3 Market size, by application, 2018-2032 (USD Million)
      • 9.4.7.4 Market size, by end-use, 2018-2032 (USD Million)
    • 9.4.8 Japan
      • 9.4.8.1 Market size, by technology, 2018-2032 (USD Million)
        • 9.4.8.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
        • 9.4.8.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
        • 9.4.8.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
      • 9.4.8.2 Market size, by product and services, 2018-2032 (USD Million)
      • 9.4.8.3 Market size, by application, 2018-2032 (USD Million)
      • 9.4.8.4 Market size, by end-use, 2018-2032 (USD Million)
    • 9.4.9 Australia
      • 9.4.9.1 Market size, by technology, 2018-2032 (USD Million)
        • 9.4.9.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
        • 9.4.9.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
        • 9.4.9.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
      • 9.4.9.2 Market size, by product and services, 2018-2032 (USD Million)
      • 9.4.9.3 Market size, by application, 2018-2032 (USD Million)
      • 9.4.9.4 Market size, by end-use, 2018-2032 (USD Million)
  • 9.5 Latin America
    • 9.5.1 Market size, by country, 2018-2032 (USD Million)
    • 9.5.2 Market size, by technology, 2018-2032 (USD Million)
      • 9.5.2.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
      • 9.5.2.2 Market size, by molecular assays, 2018-2032 (USD Million)
        • 9.5.2.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
    • 9.5.3 Market size, by product and services, 2018-2032 (USD Million)
    • 9.5.4 Market size, by application, 2018-2032 (USD Million)
    • 9.5.5 Market size, by end-use, 2018-2032 (USD Million)
    • 9.5.6 Brazil
      • 9.5.6.1 Market size, by technology, 2018-2032 (USD Million)
        • 9.5.6.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
        • 9.5.6.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
        • 9.5.6.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
      • 9.5.6.2 Market size, by product and services, 2018-2032 (USD Million)
      • 9.5.6.3 Market size, by application, 2018-2032 (USD Million)
      • 9.5.6.4 Market size, by end-use, 2018-2032 (USD Million)
    • 9.5.7 Mexico
      • 9.5.7.1 Market size, by technology, 2018-2032 (USD Million)
        • 9.5.7.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
        • 9.5.7.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
        • 9.5.7.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
      • 9.5.7.2 Market size, by product and services, 2018-2032 (USD Million)
      • 9.5.7.3 Market size, by application, 2018-2032 (USD Million)
      • 9.5.7.4 Market size, by end-use, 2018-2032 (USD Million)
  • 9.6 MEA
    • 9.6.1 Market size, by country, 2018-2032 (USD Million)
    • 9.6.2 Market size, by technology, 2018-2032 (USD Million)
      • 9.6.2.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
      • 9.6.2.2 Market size, by molecular assays, 2018-2032 (USD Million)
        • 9.6.2.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
    • 9.6.3 Market size, by product and services, 2018-2032 (USD Million)
    • 9.6.4 Market size, by application, 2018-2032 (USD Million)
    • 9.6.5 Market size, by end-use, 2018-2032 (USD Million)
    • 9.6.6 South Africa
      • 9.6.6.1 Market size, by technology, 2018-2032 (USD Million)
        • 9.6.6.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
        • 9.6.6.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
        • 9.6.6.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
      • 9.6.6.2 Market size, by product and services, 2018-2032 (USD Million)
      • 9.6.6.3 Market size, by application, 2018-2032 (USD Million)
      • 9.6.6.4 Market size, by end-use, 2018-2032 (USD Million)
    • 9.6.7 Saudi Arabia
      • 9.6.7.1 Market size, by technology, 2018-2032 (USD Million)
        • 9.6.7.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
        • 9.6.7.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
        • 9.6.7.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
      • 9.6.7.2 Market size, by product and services, 2018-2032 (USD Million)
      • 9.6.7.3 Market size, by application, 2018-2032 (USD Million)
      • 9.6.7.4 Market size, by end-use, 2018-2032 (USD Million)

Chapter 10 Company Profiles

  • 10.1 Abbott Laboratories
    • 10.1.1 Business overview
    • 10.1.2 Financial data
    • 10.1.3 Product landscape
    • 10.1.4 Strategic outlook
    • 10.1.5 SWOT analysis
  • 10.2 Bio-Rad Laboratories
    • 10.2.1 Business overview
    • 10.2.2 Financial data
    • 10.2.3 Product landscape
    • 10.2.4 Strategic outlook
    • 10.2.5 SWOT analysis
  • 10.3 BioReference Laboratories
    • 10.3.1 Business overview
    • 10.3.2 Financial data
    • 10.3.3 Product landscape
    • 10.3.4 SWOT analysis
  • 10.4 CareDx, Inc.
    • 10.4.1 Business overview
    • 10.4.2 Financial data
    • 10.4.3 Product landscape
    • 10.4.4 Strategic outlook
    • 10.4.5 SWOT analysis
  • 10.5 GenDx
    • 10.5.1 Business overview
    • 10.5.2 Financial data
    • 10.5.3 Product landscape
    • 10.5.4 Strategic outlook
    • 10.5.5 SWOT analysis
  • 10.6 Illumina Inc.
    • 10.6.1 Business overview
    • 10.6.2 Financial data
    • 10.6.3 Product landscape
    • 10.6.4 Strategic outlook
    • 10.6.5 SWOT analysis
  • 10.7 Immucor Inc.
    • 10.7.1 Business overview
    • 10.7.2 Financial data
    • 10.7.3 Product landscape
    • 10.7.4 Strategic outlook
    • 10.7.5 SWOT analysis
  • 10.8 Inno-train Diagnostik GmbH
    • 10.8.1 Business overview
    • 10.8.2 Financial data
    • 10.8.3 Product landscape
    • 10.8.4 SWOT analysis
  • 10.9 Luminex Corporation
    • 10.9.1 Business overview
    • 10.9.2 Financial data
    • 10.9.3 Product landscape
    • 10.9.4 SWOT analysis
  • 10.10 Omixon, Inc
    • 10.10.1 Business overview
    • 10.10.2 Financial data
    • 10.10.3 Product landscape
    • 10.10.4 Strategic outlook
    • 10.10.5 SWOT analysis
  • 10.11 Pacific Biosciences of California, Inc
    • 10.11.1 Business overview
    • 10.11.2 Financial data
    • 10.11.3 Product landscape
    • 10.11.4 Strategic outlook
    • 10.11.5 SWOT analysis
  • 10.12 Qiagen N.V.
    • 10.12.1 Business overview
    • 10.12.2 Financial data
    • 10.12.3 Product landscape
    • 10.12.4 SWOT analysis
  • 10.13 F. Hoffmann-La Roche Ltd
    • 10.13.1 Business overview
    • 10.13.2 Financial data
    • 10.13.3 Product landscape
    • 10.13.4 SWOT analysis
  • 10.14 Thermo-Fisher Scientific Inc.
    • 10.14.1 Business overview
    • 10.14.2 Financial data
    • 10.14.3 Product landscape
    • 10.14.4 Strategic outlook
    • 10.14.5 SWOT analysis
  • 10.15 Fujirebio
    • 10.15.1 Business overview
    • 10.15.2 Financial data
    • 10.15.3 Product landscape
    • 10.15.4 SWOT analysis
  • 10.16 BAG Diagnostic GmbH
    • 10.16.1 Business overview
    • 10.16.2 Financial data
    • 10.16.3 Product landscape
    • 10.16.4 SWOT analysis
  • 10.17 GMSbiotech, Inc.
    • 10.17.1 Business overview
    • 10.17.2 Financial data
    • 10.17.3 Product landscape
    • 10.17.4 SWOT analysis
  • 10.18 Biofortuna Limited
    • 10.18.1 Business overview
    • 10.18.2 Financial data
    • 10.18.3 Product landscape
    • 10.18.4 Strategic outlook
    • 10.18.5 SWOT analysis
  • 10.19 TBG Diagnostics Limited
    • 10.19.1 Business overview
    • 10.19.2 Financial data
    • 10.19.3 Product landscape
    • 10.19.4 Strategic outlook
    • 10.19.5 SWOT analysis